Duncan Jason 4/A
4/A · ALBIREO PHARMA, INC. · Filed Jan 27, 2023
Insider Transaction Report
Form 4/AAmended
Duncan Jason
General Counsel
Transactions
- Award
Common Stock
2023-01-19+55,000→ 69,146 total
Footnotes (2)
- [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% of the shares on January 19, 2024, 6.25% of the shares every three months thereafter beginning on April 19, 2024 and ending on January 19, 2025, and 12.5% of the shares every three months thereafter beginning on April 19, 2025 and ending on January 19, 2026.
- [F2]Represents 3,296 shares of common stock and 65,850 restricted stock units.